TMJ Stock Overview
Through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Globe Life Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$107.00 |
| 52 Week High | US$122.00 |
| 52 Week Low | US$72.00 |
| Beta | 0.56 |
| 1 Month Change | 0.94% |
| 3 Month Change | -9.32% |
| 1 Year Change | 33.75% |
| 3 Year Change | 16.30% |
| 5 Year Change | 59.70% |
| Change since IPO | 640.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| TMJ | DE Insurance | DE Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | 0.4% |
| 1Y | 33.8% | 33.9% | 13.1% |
Return vs Industry: TMJ matched the German Insurance industry which returned 33.1% over the past year.
Return vs Market: TMJ exceeded the German Market which returned 13.2% over the past year.
Price Volatility
| TMJ volatility | |
|---|---|
| TMJ Average Weekly Movement | 6.1% |
| Insurance Industry Average Movement | 4.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in DE Market | 12.9% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: TMJ has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: TMJ's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1900 | 3,732 | Frank Svoboda | www.home.globelifeinsurance.com |
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates through three segments: Life Insurance, Supplemental Health Insurance, and Investments. It offers whole, term, and other life insurance products; and Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products.
Globe Life Inc. Fundamentals Summary
| TMJ fundamental statistics | |
|---|---|
| Market cap | €8.94b |
| Earnings (TTM) | €951.79m |
| Revenue (TTM) | €5.19b |
9.4x
P/E Ratio1.7x
P/S RatioIs TMJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TMJ income statement (TTM) | |
|---|---|
| Revenue | US$5.84b |
| Cost of Revenue | US$3.93b |
| Gross Profit | US$1.91b |
| Other Expenses | US$840.53m |
| Earnings | US$1.07b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.98 |
| Gross Margin | 32.72% |
| Net Profit Margin | 18.33% |
| Debt/Equity Ratio | 58.4% |
How did TMJ perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield8%
Payout RatioDoes TMJ pay a reliable dividends?
See TMJ dividend history and benchmarks| Globe Life dividend dates | |
|---|---|
| Ex Dividend Date | Jul 03 2025 |
| Dividend Pay Date | Aug 01 2025 |
| Days until Ex dividend | 51 days |
| Days until Dividend pay date | 80 days |
Does TMJ pay a reliable dividends?
See TMJ dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/12 09:44 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Globe Life Inc. is covered by 31 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jay Gelb | Barclays |
| null null | BMO Capital Markets Equity Research |
| Ian Ryave | BofA Global Research |